Conformis IP Buys Time for New Products

By Mike Evers

Conformis IP Buys Time for New Products
The company benefitted from $41 million in one-time royalty and settlement payments in 2Q21 but its product revenue remains down vs. 2019.

Member-Only Content

SUBSCRIBE Login

Product Labels: Hip Replacement, Knee Replacement

Tags: Revenue Report